Articles
-
Telling Doctors Their Patients Fatally Overdosed Reduces Opioid Prescriptions Up to One Year Later
Those clinicians who received the letter wrote 7% fewer prescriptions than clinicians who hadn’t received the notification.
Categorized in -
Protected: Curing What Ails Healthcare Markets Conference Proceedings
There is no excerpt because this is a protected post.
Categorized in -
Social and Biomedical Scientists Come Together to Address the Burden of Alzheimer’s Disease
Social scientists are uniquely poised to evaluate the implications of Alzheimer’s costs, yet they often lack knowledge of the biomedical foundations of the disease.
Categorized in -
Shame Won’t Solve America’s Obesity Crisis: How Congress Can Help
If saving lives is the objective, then logic, clinical evidence and compassion dictate that Medicare should pay for preventing and treating obesity, starting now.
Categorized in -
High-Tech Map Promotes Access to Medicine and Pharmacy Services
A USC-developed interactive mapping tool shows the location of every pharmacy in the United States — and which neighborhoods are “pharmacy deserts.”
-
New Dialysis Studies Inform Delivery of Care, Ways to Improve Patient Outcomes
Researchers analyzed the effects of clinic ownership and dialysis timing on patient outcomes.
Categorized in -
The Inflation Reduction Act Is Already Killing Potential Cures
The law’s price controls do away with incentives for research and development of life-saving drugs.
Categorized in -
Applying for the 2023-2024 Roybal Center for Behavioral Interventions in Aging Pilot Projects
The Roybal Center for Behavioral Interventions in Aging seeks proposals for pilot projects that involve randomized controlled trials (RCTs).
-
Pregnancy and Pot: Healthy Alternative or Bad for Baby?
Is cannabis an organic remedy for morning sickness or danger to an unborn child?
Categorized in -
Comments on AHRQ Analysis of Requirements for Coverage with Evidence Development
Researchers submitted a comment letter on the Agency for Healthcare Research and Quality (AHRQ)’s analysis for the Center for Medicare and Medicaid Services (CMS)’s requirements for Coverage with Evidence Development (CED) study design.
Categorized in